Recent high-profile cases of COVID-19 combined with the effort to aid in the ongoing battle against the pandemic have prompted RADLogics to deploy the company’s AI (Artificial Intelligence)-Powered medical image analysis solution worldwide. The company urged U.S. clinicians to embrace medical imaging and emerging technologies such as AI. RADLogics has an AI-powered solution in place which has processed and analyzed thousands of suspected coronavirus cases globally. These efforts have eased the surging workload for radiology, ER, and ICU teams worldwide.
RADLogics strives to make its CT and X-ray
AI-powered technology available to hospitals and healthcare systems throughout
the U.S. This technology will assist in COVID-19 patient triage and management
by providing quantitative analysis to clinical teams. Those patients who
exhibit severe or worsening respiratory conditions are accurately assessed, allowing
doctors to better triage patients based on those who urgently need intensive
care such as ventilator support.
Moshe
Becker, CEO and Co-Founder of RADLogics, said, “The
use of CT and X-ray in the assessment and treatment plan for President
Trump underscores the critical role that medical
imaging must play in the fight against COVID-19. We must scale the capabilities
of these medical imaging procedures rapidly to support clinicians, hospitals,
and healthcare systems throughout the U.S. as they respond to the anticipated
second wave of coronavirus and the roll-out of a potential vaccine. Now is the
time for hospitals and healthcare providers to embrace and leverage the power
of AI technologies and solutions to not only alleviate the increased burden
associated with COVID-19 but to help support better outcomes by reducing
burnout and errors while delivering better patient outcomes.”
Eliot
Siegel, MD, Associate Vice Chair of Diagnostic
Radiology and Nuclear Medicine at the University of Maryland School of Medicine
said, “The ability of medical imaging – in combination with AI – to better
discover and quantify the burden of COVID-19 has been well-documented. There
would be tremendous clinical value in an AI algorithm that could establish and
utilize a trajectory of change to predict which subset of patients might need
more intense therapy such as medical ventilation, which subset of patients
could be more confidently discharged, and predict subsequent clinical course.
Today, there are many promising AI applications that have emerged that could
allow us to address the major challenges that have hit the healthcare sector
during the pandemic, and beyond as we plan to treat patients with COVID-related
complications and as we provide diagnostic and therapeutic procedures that were
delayed during the surge.”
Acceletronics is an industry leader in delivering the best equipment
performance and service reliability from CT Scanners and Linear Accelerators
across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.
Written by the digital marketing staff at
Creative Programs & Systems: www.cpsmi.com.